Evidence map›Paper›PMID 24068662›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Neuraminidase reprograms lung tissue and potentiates lipopolysaccharide-induced acute lung injury in mice.

Chiguang Feng, Lei Zhang, Chinh Nguyen, Stefanie N Vogel, Simeon E Goldblum, William C Blackwelder, Alan S Cross

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Review
  8. The Janus-like role of neuraminidase isoenzymes in inflammation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  9. Sialic acid blockade in dendritic cells enhances CD8Cellular and molecular life sciences : CMLS · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Inhibiting Sialidase-Induced TGF-The Journal of pharmacology and experimental therapeutics · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chiguang FengCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201;
Lei Zhang
Chinh Nguyen
Stefanie N Vogel
Simeon E Goldblum
William C Blackwelder
Alan S Cross
University of Maryland, Baltimore · US

Funding

DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATIONR37AI018797 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2000 to 2009
$5.3M
Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
DIFFERENTIATIVE SIGNALS FOR MACROPHANGE ACTIVATIONR01AI018797 · NIAID · U.S. UNIFORMED SERVICES UNIV OF HLTH SCI · PI VOGEL, STEFANIE N. · 1985 to 2014
$3.8M
Role of Sialidase in Pulmonary Host Defenses and Acute Lung InjuryR01HL086933 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI CROSS, ALAN S. · 2007 to 2010
$1.8M
Endotoxin TLR4 Signaling Regulates Lung Endothelial Paracellular PathwayR01HL089179 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI GOLDBLUM, SIMEON EMANUEL · 2009 to 2012
$1.5M
Differentiative Signals for Macrophage ActivationR56AI018797 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2015 to 2015
$506k
NEU1 Sialidase Disrupts CD31-Driven Angiogenesis in Human Lung EndotheliaI01BX002352 · VA · BALTIMORE VA MEDICAL CENTER · PI GOLDBLUM, SIMEON EMANUEL · 2015 to 2018
–
BLRD VA I01 BX002352NHLBI NIH HHS HL086933-01A1NHLBI NIH HHS HL089179NHLBI NIH HHS R01 HL086933NHLBI NIH HHS R01 HL089179NIAID NIH HHS AI018797NIAID NIH HHS R01 AI018797NIAID NIH HHS R37 AI018797NIAID NIH HHS R56 AI018797NIAID NIH HHS T32 AI095190
6 · The paper itself

Abstract

We previously reported that removal of sialyl residues primed PBMCs to respond to bacterial LPS stimulation in vitro. Therefore, we speculated that prior desialylation can sensitize the host to generate an enhanced inflammatory response upon exposure to a TLR ligand, such as LPS, in a murine model of acute lung injury. Intratracheal instillation of neuraminidase (NA) 30 min prior to intratracheal administration of LPS increased polymorphonuclear leukocytes (PMNs) in the bronchoalveolar lavage fluid and the wet-to-dry lung weight ratio, a measure of pulmonary edema, compared with mice that received LPS alone. Administration of NA alone resulted in desialylation of bronchiolar and alveolar surfaces and induction of TNF-α, IL-1β, and chemokines in lung homogenates and bronchoalveolar lavage fluid; however, PMN recruitment in mice treated with NA alone did not differ from that of PBS-administered controls. NA pretreatment alone induced apoptosis and markedly enhanced LPS-induced endothelial apoptosis. Administration of recombinant Bcl-2, an antiapoptotic molecule, abolished the effect of NA treatment on LPS-induced PMN recruitment and pulmonary edema formation. We conclude that NA pretreatment potentiates LPS-induced lung injury through enhanced PMN recruitment, pulmonary edema formation, and endothelial and myeloid cell apoptosis. A similar "reprogramming" of immune responses with desialylation may occur during respiratory infection with NA-expressing microbes and contribute to severe lung injury.

Indexed as

Acute Lung InjuryAnimalsApoptosisBronchoalveolar Lavage FluidDisease Models, AnimalEndothelial CellsLipopolysaccharidesLungMiceMice, Inbred C57BLMice, KnockoutMyeloid CellsN-Acetylneuraminic AcidNeuraminidaseNeutrophilsProto-Oncogene Proteins c-bcl-2LipopolysaccharidesN-Acetylneuraminic AcidNeuraminidaseProto-Oncogene Proteins c-bcl-2

Identifiers

PMID24068662
PMCPMC3839962
OpenAlexW1528847947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.